Showing results (51-60 of 135) with videos related to
Sort By:
Pageof 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1989
Metabolism of the antianxiety drug buspirone in the ratH K Jajoo, R F Mayol, J A LaBudde, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 1, 1990
In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivoH K Jajoo, I A Blair, L J Klunk, et al.Biomedical & Environmental Mass Spectrometry|May 1, 1990
Characterization of in vitro metabolites of the antipsychotic drug tiospirone by mass spectrometryH K Jajoo, I A Blair, L J Klunk, et al.Pharmacogenetics|February 1, 1994
Stereoselective disposition of hexobarbital and its metabolites: relationship to the S-mephenytoin polymorphism in Caucasian and Chinese subjectsA Adedoyin, C Prakash, D O'Shea, et al.Lancet (London, England)|February 12, 1983
Release of prostacyclin in vivo and its role in manJ M Ritter, S E Barrow, I A Blair, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1990
Structural characterization of urinary metabolites of the antiarrhythmic drug encainide in human subjectsH K Jajoo, R F Mayol, J A LaBudde, et al.The American Review of Respiratory Disease|December 1, 1990
Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheepB W Christman, P L Lefferts, I A Blair, et al.Carcinogenesis|May 1, 1996
Characterization of an N6-oxopropenyl-2'-deoxyadenosine adduct in malondialdehyde-modified DNA using liquid chromatography/electrospray ionization tandem mass spectrometryA K Chaudhary, G R Reddy, I A Blair, et al.Carcinogenesis|December 1, 1994
Phospholipid peroxidation in tumor promoter-exposed mouse skinJ K Beckman, F Bagheri, C Ji, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1991
Geometric isomerization of doxepin during its N-demethylation in humansH Ghabrial, C Prakash, U G Tacke, et al.Pageof 14